Mutated FGFR4 protein helps a childhood cancer spread
Rhabdomyosarcoma (RMS) is a childhood cancer thought to originate from skeletal muscle. In patients whose disease has spread (metastasized) from the initial tumor site the chance of long-term survival...
View ArticleNovel breast tissue feature may predict woman's cancer risk
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical...
View ArticleNew chemo cocktail blocks breast cancer like a strong fence
Think of a protective fence that blocks the neighbor's dog from charging into your backyard. The body, too, has fences -- physical and biochemical barriers that keep cells in their place.read more
View ArticleNovel polymer delivers genetic medicine, allows tracking
Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can...
View ArticleNew treatment more than doubles survival for high risk childhood leukemia
Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular...
View ArticleGenetic variation of enzyme linked with outcomes for women receiving tamoxifen
Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7...
View ArticleM. D. Anderson team chosen to help navigate Cancer Genome Atlas
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the...
View ArticleRare head and neck cancer linked to HPV, study finds
An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive...
View ArticleSurgeons' unanimous consensus: Needle biopsy is gold standard for breast...
A special report published in the October issue of the Journal of the American College of Surgeons indicates that an alarming 35% of initial diagnostic breast biopsies in the United States are still...
View ArticleTGen and Scottsdale Healthcare discover new 'pathways'
Using computer modeling, the Translational Genomics Research Institute and Scottsdale Healthcare have discovered lung cancer 'pathways' that could become targets for new drugs, according to a...
View ArticleResearcher solves mystery about proteins that package the genome
A Florida State University College of Medicine researcher has solved a century-old mystery about proteins that play a vital role in the transfer of the human genetic code from one cell to another. The...
View ArticleGenes signal late-stage laryngeal cancer, poorer outcome
Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current...
View ArticleGenetic effects of radiation in cancer survivors and their children
Researchers at the University of Oklahoma Health Sciences Center are helping to lead a massive international study on the possible genetic effects of radiation and cancer drug exposures on future...
View ArticleAfrican American lung cancer patients may have different response to new...
Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which...
View ArticleKnome Personal Genomics Service Expands to Include 93,000 Rare Mutations from...
Knome, a recognized pioneer in the personal genomics industry, announced today that it is incorporating information from The Human Gene Mutation Database (HGMD® - Cardiff University, UK) distributed by...
View ArticleLeptin linked with more aggressive thyroid cancer in Middle Eastern region
Leptin, a molecule linked with obesity, may play a crucial role in predicting poor prognosis from thyroid cancer, at least in the Middle Eastern region of the world, according to data presented at the...
View ArticleBreast cancer patients with high risk gene diagnosed 6 years earlier than...
Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new...
View ArticleStudy finds no relationship between PCR rate and race in women with breast...
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete...
View ArticleKEAP1 Keeps major cancer-promoting protein at bay
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M....
View ArticleAlthough more older women receive breast-conserving therapy, gaps in...
According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being...
View ArticleIncreased levels of Muellerian-inhibiting substance could mean greater breast...
Women with increased levels of Müllerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new...
View ArticleDNAVision Announces Illumina CSPro Certification for Infinium Genotyping...
Liege, 20th November – DNAVision, a European-based genomic service provider, announced today that it has successfully completed Illumina CSPro™ certification for Infinium Genotyping, gaining entry to...
View ArticleBeijing Genomics Institute-Hong Kong (BGI-HK) and DNAVISION partner on next...
Belgian Embassy in Beijing, November 23th 2009 – DNAVision one of the European leading genetic analysis service provider, and the Beijing Genomics Institute-Hong Kong (BGI-HK, a spin-off of Beijing...
View ArticleOmega-3 fatty acids may reduce risk of colon cancer
Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research...
View ArticleGenetic variations indicate risk of recurrence, secondary cancer among head...
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The...
View ArticleLandmark study confirms chemotherapy benefit in breast cancer patients
Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System.read more
View ArticleEntroGen Enters Into an Agreement With Childrens Hospital Los Angeles to...
TARZANA, Calif., April 16, 2010 --- Today, EntroGen announced that it has entered into a collaboration and licensing agreement with the Childrens Hospital Los Angeles to develop a molecular diagnostic...
View ArticleDNAVISION ORDERS EUROPE’S FIRST HIScanSQ™ FOR COMMERCIAL USE
Brussels (Belgium) 17th May 2010 – DNAVision, one of Europe’s leading genetic analysis service providers, is pleased to announce the purchase of Illumina’s new HiScanSQ™ microarray and next-generation...
View ArticleDNAVISION ORDERS SECOND ILLUMINA HISeq2000™ FOR COMMERCIAL USE
Brussels (Belgium) 27th August 2010 – DNAVision, Europe’s leading genetic analysis service providers, is pleased to announce the acquisition beginning of August of an additional Illumina HiSeq 2000...
View ArticlePfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating...
Pfizer Inc. announced today that the PROFILE 1007 study met its primary endpoint, demonstrating that XALKORI® (crizotinib) significantly improved progression-free survival (PFS) when compared with...
View Article
